Upside in Madrigal Pharmaceuticals (MDGL) attributed to M&A chatter on Betaville with Eli Lilly (LLY) rumoured to be potential buyer - UNCONFIRMED

Newsquawk StaffPublished
Newsquawk headlinesUTC

Every headline is on the live feed 20 minutes before this site.

Senate Republicans pushing Trump to declare national emergency to pay TSA Agents, WSJ reports, citing sources

Meta (META) now plans to spend USD 10bln on its AI data center in El Paso, Texas, up from a prior commitment of USD 1.5bln, via CNBC

Upside in Madrigal Pharmaceuticals (MDGL) attributed to M&A chatter on Betaville with Eli Lilly (LLY) rumoured to be potential buyer - UNCONFIRMED

PRIMER - Today's afterhours Fedspeak includes voters Miran, Jefferson, Barr, Cook

Mexican Interest Rate Decision 6.75% vs. Exp. 7% (Prev. 7%); 3 voted to cut rates, 2 voted for hold

On the Newsquawk feed at , 20 minutes before this page.

Use the PlatformFree. No signup, no card.

Context

The speculation around Madrigal Pharmaceuticals being a potential acquisition target for Eli Lilly suggests there could be strategic interests at play. While unconfirmed, this chatter could drive interest and volatility in MDGL's shares, as markets generally react positively to M&A rumors due to the premium typically associated with buyouts.

Related headlines

The feed had this first.

Use the Platform